{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:51:56Z","timestamp":1783813916725,"version":"3.55.0"},"publisher-location":"Cham","reference-count":189,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030340247","type":"print"},{"value":"9783030340254","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-34025-4_16","type":"book-chapter","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T17:03:24Z","timestamp":1583341404000},"page":"311-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response"],"prefix":"10.1007","author":[{"given":"Ana","family":"Hip\u00f3lito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1158\/1055-9965.EPI-08-0232","volume":"17","author":"JA Abrams","year":"2008","unstructured":"Abrams JA, Lee PC, Port JL et al (2008) Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol Biomark Prev 17:2707\u20132713. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0232","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biomaterials.2017.02.023","volume":"126","author":"A Achek","year":"2017","unstructured":"Achek A, Kwon H, Lee B, Yoo TH (2017) TLR4\/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation. Biomaterials 126:49\u201360. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.02.023","journal-title":"Biomaterials"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/CCO.0b013e328356da72","volume":"24","author":"K Adekola","year":"2012","unstructured":"Adekola K, Rosen ST, Shanmugam M (2012) Glucose transporters in cancer metabolism. Curr Opin Oncol 24:650\u2013654. https:\/\/doi.org\/10.1097\/CCO.0b013e328356da72","journal-title":"Curr Opin Oncol"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/cncr.11480","volume":"98","author":"NR Agrawal","year":"2003","unstructured":"Agrawal NR, Bukowski RM, Rybicki LA et al (2003) A phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma. Cancer 98:94\u201399. https:\/\/doi.org\/10.1002\/cncr.11480","journal-title":"Cancer"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19:9\u201331","journal-title":"Nat Rev Cancer"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/1471-2407-14-955","volume":"14","author":"K Amornsupak","year":"2014","unstructured":"Amornsupak K, Insawang T, Thuwajit P et al (2014) Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells. BMC Cancer 14:955. https:\/\/doi.org\/10.1186\/1471-2407-14-955","journal-title":"BMC Cancer"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molimm.2008.08.266","volume":"46","author":"SP Bak","year":"2008","unstructured":"Bak SP, Alonso A, Turk MJ, Berwin B (2008) Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. Mol Immunol 46:258\u2013268. https:\/\/doi.org\/10.1016\/j.molimm.2008.08.266","journal-title":"Mol Immunol"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"e0139073","DOI":"10.1371\/journal.pone.0139073","volume":"10","author":"G-A Banat","year":"2015","unstructured":"Banat G-A, Tretyn A, Pullamsetti SS et al (2015) Immune and inflammatory cell composition of human lung cancer stroma. PLoS One 10:e0139073. https:\/\/doi.org\/10.1371\/journal.pone.0139073","journal-title":"PLoS One"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"B Bhattacharya","year":"2016","unstructured":"Bhattacharya B, Mohd Omar MF, Soong R (2016) The Warburg effect and drug resistance. Br J Pharmacol 173:970\u2013979. https:\/\/doi.org\/10.1111\/bph.13422","journal-title":"Br J Pharmacol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/J.IMMUNI.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M et al (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782\u2013795. https:\/\/doi.org\/10.1016\/J.IMMUNI.2013.10.003","journal-title":"Immunity"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","volume":"43","author":"SK Biswas","year":"2015","unstructured":"Biswas SK (2015) Metabolic reprogramming of immune cells in cancer progression. Immunity 43:435\u2013449. https:\/\/doi.org\/10.1016\/j.immuni.2015.09.001","journal-title":"Immunity"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, D\u00f8nnem T, Al-Saad S et al (2011) The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 6:209\u2013217. https:\/\/doi.org\/10.1097\/JTO.0b013e3181f8a1bd","journal-title":"J Thorac Oncol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.18632\/oncotarget.1958","volume":"5","author":"L Brunelli","year":"2014","unstructured":"Brunelli L, Caiola E, Marabese M et al (2014) Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells. Oncotarget 5:4722\u20134731. https:\/\/doi.org\/10.18632\/oncotarget.1958","journal-title":"Oncotarget"},{"issue":"1","key":"16_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12860-016-0104-x","volume":"17","author":"C Cammann","year":"2016","unstructured":"Cammann C, Rath A, Reichl U et al (2016) Early changes in the metabolic profile of activated CD8 + T cells. BMC Cell Biol 17(1):28. https:\/\/doi.org\/10.1186\/s12860-016-0104-x","journal-title":"BMC Cell Biol"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","volume":"33","author":"J Candido","year":"2013","unstructured":"Candido J, Hagemann T (2013) Cancer-related inflammation. J Clin Immunol 33:79\u201384. https:\/\/doi.org\/10.1007\/s10875-012-9847-0","journal-title":"J Clin Immunol"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D et al (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229\u20131241. https:\/\/doi.org\/10.1016\/j.cell.2015.08.016","journal-title":"Cell"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-024-1170-6_1","volume":"1011","author":"NM Chapman","year":"2017","unstructured":"Chapman NM, Shrestha S, Chi H (2017) Metabolism in immune cell differentiation and function. Adv Exp Med Biol 1011:1\u201385","journal-title":"Adv Exp Med Biol"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1158\/1541-7786.mcr-12-0437-t","volume":"11","author":"VK Chaudhri","year":"2013","unstructured":"Chaudhri VK, Salzler GG, Dick SA et al (2013) Metabolic alterations in lung cancer\u2013associated fibroblasts correlated with increased glycolytic metabolism of the tumor. Mol Cancer Res 11:579\u2013592. https:\/\/doi.org\/10.1158\/1541-7786.mcr-12-0437-t","journal-title":"Mol Cancer Res"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS et al (2014a) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14:535\u2013546","journal-title":"Nat Rev Cancer"},{"key":"16_CR20","doi-asserted-by":"publisher","unstructured":"Chen P-H, Cai L, Kim HS et al (2014b) Metabolic diversity in human non-small cell lung cancer. Cancer Metab 2. https:\/\/doi.org\/10.1186\/2049-3002-2-s1-p13","DOI":"10.1186\/2049-3002-2-s1-p13"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen F, Zhuang X, Lin L et al (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13:45","journal-title":"BMC Med"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.lungcan.2012.11.021","volume":"79","author":"H Choi","year":"2013","unstructured":"Choi H, Paeng JC, Kim DW et al (2013) Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET\/CT. Lung Cancer 79:242\u2013247. https:\/\/doi.org\/10.1016\/j.lungcan.2012.11.021","journal-title":"Lung Cancer"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2017.12.005","volume":"115","author":"E Ciamporcero","year":"2018","unstructured":"Ciamporcero E, Daga M, Pizzimenti S et al (2018) Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer. Free Radic Biol Med 115:447\u2013457. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.12.005","journal-title":"Free Radic Biol Med"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"70715","DOI":"10.18632\/oncotarget.12209","volume":"7","author":"R Colla","year":"2016","unstructured":"Colla R, Izzotti A, De Ciucis C et al (2016) Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma. Oncotarget 7:70715\u201370737","journal-title":"Oncotarget"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2018.10.450","volume":"130","author":"A Cruz-Berm\u00fadez","year":"2019","unstructured":"Cruz-Berm\u00fadez A, Laza-Briviesca R, Vicente-Blanco RJ et al (2019) Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-\u03b2 signaling. Free Radic Biol Med 130:163\u2013173. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.450","journal-title":"Free Radic Biol Med"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/hh1201.092998","volume":"88","author":"Z Dagher","year":"2001","unstructured":"Dagher Z, Ruderman N, Tornheim K, Ido Y (2001) Acute regulation of fatty acid oxidation and AMP-activated protein kinase in human umbilical vein endothelial cells. Circ Res 88:1276\u20131282. https:\/\/doi.org\/10.1161\/hh1201.092998","journal-title":"Circ Res"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, Barbi J, Yang H-Y et al (2011) Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146:772\u2013784. https:\/\/doi.org\/10.1016\/j.cell.2011.07.033","journal-title":"Cell"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2345","volume":"11","author":"L Das Roy","year":"2009","unstructured":"Das Roy L, Pathangey LB, Tinder TL et al (2009) Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 11:R56. https:\/\/doi.org\/10.1186\/bcr2345","journal-title":"Breast Cancer Res"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","volume":"23","author":"SM Davidson","year":"2016","unstructured":"Davidson SM, Papagiannakopoulos T, Olenchock BA et al (2016) Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer. Cell Metab 23:517\u2013528. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.007","journal-title":"Cell Metab"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nri912","volume":"2","author":"RA Daynes","year":"2002","unstructured":"Daynes RA, Jones DC (2002) Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748\u2013759","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"16_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/15384101.2018.1442622","volume":"17","author":"E De Alteriis","year":"2018","unstructured":"De Alteriis E, Carten\u00ec F, Parascandola P et al (2018) Revisiting the Crabtree\/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death. Cell Cycle 17(6):688\u2013701. https:\/\/doi.org\/10.1080\/15384101.2018.1442622","journal-title":"Cell Cycle"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2013.08.001","volume":"18","author":"K De Bock","year":"2013","unstructured":"De Bock K, Georgiadou M, Carmeliet P (2013) Role of endothelial cell metabolism in vessel sprouting. Cell Metab 18:634\u2013647. https:\/\/doi.org\/10.1016\/j.cmet.2013.08.001","journal-title":"Cell Metab"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR et al (2018) Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun 9:446. https:\/\/doi.org\/10.1038\/s41467-017-02733-4","journal-title":"Nat Commun"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.radonc.2015.08.016","volume":"116","author":"K Dittmann","year":"2015","unstructured":"Dittmann K, Mayer C, Paasch A et al (2015) Nuclear EGFR renders cells radio-resistant by binding mRNA species and triggering a metabolic switch to increase lactate production. Radiother Oncol 116:431\u2013437","journal-title":"Radiother Oncol"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.freeradbiomed.2010.01.015","volume":"48","author":"BP Dranka","year":"2010","unstructured":"Dranka BP, Hill BG, Darley-Usmar VM (2010) Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 48:905\u2013914. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.01.015","journal-title":"Free Radic Biol Med"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2017.09.039","volume":"411","author":"E Dugnani","year":"2017","unstructured":"Dugnani E, Pasquale V, Bordignon C et al (2017) Integrating T cell metabolism in cancer immunotherapy. Cancer Lett 411:12\u201318. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.039","journal-title":"Cancer Lett"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/147323000803600112","volume":"36","author":"E Dundar","year":"2008","unstructured":"Dundar E, Oner U, Peker BC et al (2008) The significance and relationship between mast cells and tumour angiogenesis in non-small cell lung carcinoma. J Int Med Res 36:88\u201395. https:\/\/doi.org\/10.1177\/147323000803600112","journal-title":"J Int Med Res"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/omi.2016.0152","volume":"20","author":"K Dzobo","year":"2016","unstructured":"Dzobo K, Senthebane DA, Rowe A et al (2016) Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf. Omi A J Integr Biol 20:681\u2013691. https:\/\/doi.org\/10.1089\/omi.2016.0152","journal-title":"Omi A J Integr Biol"},{"issue":"4","key":"16_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","volume":"8","author":"JML Ebos","year":"2011","unstructured":"Ebos JML, Kerbel RS (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 8(4):210\u2013221","journal-title":"Nat Rev Clin Oncol"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-8-41","volume":"8","author":"TWM Fan","year":"2009","unstructured":"Fan TWM, Lane AN, Higashi RM et al (2009) Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol Cancer 8:41. https:\/\/doi.org\/10.1186\/1476-4598-8-41","journal-title":"Mol Cancer"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L et al (2017) Lactate metabolism in human lung tumors. Cell 171:358\u2013371.e9. https:\/\/doi.org\/10.1016\/j.cell.2017.09.019","journal-title":"Cell"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"66ra5","DOI":"10.1126\/scitranslmed.3001542","volume":"3","author":"JW Franses","year":"2011","unstructured":"Franses JW, Baker AB, Chitalia VC, Edelman ER (2011) Stromal endothelial cells directly influence cancer progression. Sci Transl Med 3:66ra5. https:\/\/doi.org\/10.1126\/scitranslmed.3001542","journal-title":"Sci Transl Med"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth KA, Riley JL, Harris MH et al (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769\u2013777. https:\/\/doi.org\/10.1016\/S1074-7613(02)00323-0","journal-title":"Immunity"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.biocel.2007.03.021","volume":"39","author":"RA Gatenby","year":"2007","unstructured":"Gatenby RA, Gillies RJ (2007) Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol 39:1358\u20131366. https:\/\/doi.org\/10.1016\/j.biocel.2007.03.021","journal-title":"Int J Biochem Cell Biol"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1139\/bcb-2016-0197","volume":"95","author":"A Giatromanolaki","year":"2017","unstructured":"Giatromanolaki A, Liousia M, Arelaki S et al (2017) Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism. Biochem Cell Biol 95:428\u2013436. https:\/\/doi.org\/10.1139\/bcb-2016-0197","journal-title":"Biochem Cell Biol"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cytogfr.2017.03.004","volume":"35","author":"JNR Gnanaprakasam","year":"2017","unstructured":"Gnanaprakasam JNR, Sherman JW, Wang R (2017) MYC and HIF in shaping immune response and immune metabolism. Cytokine Growth Factor Rev 35:63\u201370. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.03.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"59766","DOI":"10.18632\/oncotarget.11121","volume":"7","author":"S Gon\u00e7alves-Ribeiro","year":"2016","unstructured":"Gon\u00e7alves-Ribeiro S, D\u00edaz-Maroto NG, Berdiel-Acer M et al (2016) Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells. Oncotarget 7:59766\u201359780. https:\/\/doi.org\/10.18632\/oncotarget.11121","journal-title":"Oncotarget"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semradonc.2010.01.003","volume":"20","author":"EE Graves","year":"2010","unstructured":"Graves EE, Maity A, Le QT (2010) The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol 20:156\u2013163","journal-title":"Semin Radiat Oncol"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nm.2439","volume":"17","author":"G Haemmerle","year":"2011","unstructured":"Haemmerle G, Moustafa T, Woelkart G et al (2011) ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat Med 17:1076\u20131085. https:\/\/doi.org\/10.1038\/nm.2439","journal-title":"Nat Med"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309\u2013322","journal-title":"Cancer Cell"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Leading edge review hallmarks of Cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL (2002) Hypoxia\u00a0\u2014 a key regulatory factor in tumour growth. Nat Rev Cancer 2:38\u201347. https:\/\/doi.org\/10.1038\/nrc704","journal-title":"Nat Rev Cancer"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"110656","DOI":"10.18632\/oncotarget.22529","volume":"8","author":"X He","year":"2017","unstructured":"He X, Du S, Lei T et al (2017) PKM2 in carcinogenesis and oncotherapy. Oncotarget 8:110656\u2013110670. https:\/\/doi.org\/10.18632\/oncotarget.22529","journal-title":"Oncotarget"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley CT, Faubert B, Yuan Q et al (2016) Metabolic heterogeneity in human lung tumors. Cell 164:681\u2013694. https:\/\/doi.org\/10.1016\/j.cell.2015.12.034","journal-title":"Cell"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1200\/JCO.2005.18.853","volume":"23","author":"RS Herbst","year":"2005","unstructured":"Herbst RS, Onn A, Sandler A (2005) Angiogenesis and lung cancer: prognostic and therapeutic implications. J Clin Oncol 23:3243\u20133256. https:\/\/doi.org\/10.1200\/JCO.2005.18.853","journal-title":"J Clin Oncol"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.18632\/oncotarget.13475","volume":"8","author":"K Hientz","year":"2017","unstructured":"Hientz K, Mohr A, Bhakta-Guha D, Efferth T (2017) The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget 8:8921\u20138946. https:\/\/doi.org\/10.18632\/oncotarget.13475","journal-title":"Oncotarget"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL et al (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389:299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8","journal-title":"Lancet"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1242\/jcs.182873","volume":"129","author":"GA Hobbs","year":"2016","unstructured":"Hobbs GA, Der CJ, Rossman KL (2016) RAS isoforms and mutations in cancer at a glance. J Cell Sci 129:1287\u20131292. https:\/\/doi.org\/10.1242\/jcs.182873","journal-title":"J Cell Sci"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.3390\/cancers9080107","volume":"9","author":"P Hofman","year":"2017","unstructured":"Hofman P (2017) ALK in non-small cell lung cancer (NSCLC) pathobiology, epidemiology, detection from tumor tissue and algorithm diagnosis in a daily practice. Cancers (Basel) 9:E107","journal-title":"Cancers (Basel)"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc3477","volume":"13","author":"AM Houghton","year":"2013","unstructured":"Houghton AM (2013) Mechanistic links between COPD and lung cancer. Nat Rev Cancer 13:233\u2013245. https:\/\/doi.org\/10.1038\/nrc3477","journal-title":"Nat Rev Cancer"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2019.04.021","volume":"455","author":"Q Huang","year":"2019","unstructured":"Huang Q, Chen Z, Cheng P et al (2019) LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation. Cancer Lett 455:36\u201347. https:\/\/doi.org\/10.1016\/j.canlet.2019.04.021","journal-title":"Cancer Lett"},{"key":"16_CR62","doi-asserted-by":"crossref","unstructured":"I H, Cho J-Y (2015) Lung. Cancer Biomark:107\u2013170","DOI":"10.1016\/bs.acc.2015.07.003"},{"key":"16_CR63","doi-asserted-by":"publisher","unstructured":"Inamura K (2017) Lung cancer: understanding its molecular pathology and the 2015 WHO classification. Front Oncol 7. https:\/\/doi.org\/10.3389\/fonc.2017.00193","DOI":"10.3389\/fonc.2017.00193"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.004","volume":"17","author":"G Ishii","year":"2017","unstructured":"Ishii G (2017) Crosstalk between cancer associated fibroblasts and cancer cells in the tumor microenvironment after radiotherapy. EBioMedicine 17:7\u20138. https:\/\/doi.org\/10.1016\/j.ebiom.2017.03.004","journal-title":"EBioMedicine"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","volume":"180","author":"SR Jacobs","year":"2008","unstructured":"Jacobs SR, Herman CE, Maciver NJ et al (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180:4476\u20134486. https:\/\/doi.org\/10.4049\/jimmunol.180.7.4476","journal-title":"J Immunol"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1038\/emm.2013.85","volume":"45","author":"M Jang","year":"2013","unstructured":"Jang M, Kim SS, Lee J (2013) Cancer cell metabolism: implications for therapeutic targets. Exp Mol Med 45:e45. https:\/\/doi.org\/10.1038\/emm.2013.85","journal-title":"Exp Mol Med"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41388-018-0307-z","volume":"37","author":"X Ji","year":"2018","unstructured":"Ji X, Qian J, Rahman SMJ et al (2018) xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene 37:5007\u20135019. https:\/\/doi.org\/10.1038\/s41388-018-0307-z","journal-title":"Oncogene"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.2147\/OTT.S176818","volume":"11","author":"T Jiang","year":"2018","unstructured":"Jiang T, Zhou M-L, Fan J (2018) Inhibition of GLUT-1 expression and the PI3K\/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro. Onco Targets Ther 11:7865\u20137872. https:\/\/doi.org\/10.2147\/OTT.S176818","journal-title":"Onco Targets Ther"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.3390\/ijms160511055","volume":"16","author":"CR Justus","year":"2015","unstructured":"Justus CR, Sanderlin EJ, Yang LV (2015) Molecular connections between cancer cell metabolism and the tumor microenvironment. Int J Mol Sci 16:11055\u201311086. https:\/\/doi.org\/10.3390\/ijms160511055","journal-title":"Int J Mol Sci"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1038\/ncomms14381","volume":"9","author":"J Kargl","year":"2017","unstructured":"Kargl J, Busch SE, Yang GHY et al (2017) Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat Commun 9:E468\u2013E469. https:\/\/doi.org\/10.1038\/ncomms14381","journal-title":"Nat Commun"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"e0216328","DOI":"10.1371\/journal.pone.0216328","volume":"14","author":"SE Karol","year":"2019","unstructured":"Karol SE, Janke LJ, Panetta JC et al (2019) Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. PLoS One 14:e0216328. https:\/\/doi.org\/10.1371\/journal.pone.0216328","journal-title":"PLoS One"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1158\/1078-0432.CCR-14-2791","volume":"21","author":"R Katayama","year":"2015","unstructured":"Katayama R, Lovly CM, Shaw AT (2015) Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine. Clin Cancer Res 21:2227\u20132235. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2791","journal-title":"Clin Cancer Res"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10147-017-1156-4","volume":"22","author":"K Kawada","year":"2017","unstructured":"Kawada K, Toda K, Sakai Y (2017) Targeting metabolic reprogramming in KRAS-driven cancers. Int J Clin Oncol 22:651\u2013659. https:\/\/doi.org\/10.1007\/s10147-017-1156-4","journal-title":"Int J Clin Oncol"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469\u20131480. https:\/\/doi.org\/10.1124\/mol.106.027029","journal-title":"Mol Pharmacol"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/bjc.2011.524","volume":"106","author":"MP Kelly","year":"2012","unstructured":"Kelly MP, Jungbluth AA, Wu BW et al (2012) Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. Br J Cancer 106:324\u2013332. https:\/\/doi.org\/10.1038\/bjc.2011.524","journal-title":"Br J Cancer"},{"key":"16_CR76","first-page":"2877","volume":"31","author":"P Keohavong","year":"2011","unstructured":"Keohavong P, Kahkonen B, Kinchington E et al (2011) K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation. Anticancer Res 31:2877\u20132882","journal-title":"Anticancer Res"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/febs.14125","volume":"285","author":"EM Kerr","year":"2018","unstructured":"Kerr EM, Martins CP (2018) Metabolic rewiring in mutant Kras lung cancer. FEBS J 285:28\u201341","journal-title":"FEBS J"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-019-1050-1","volume":"38","author":"SH Kim","year":"2019","unstructured":"Kim SH, Song Y, Seo HR (2019) GSK-3\u03b2 regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models. J Exp Clin Cancer Res 38:46. https:\/\/doi.org\/10.1186\/s13046-019-1050-1","journal-title":"J Exp Clin Cancer Res"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"AC Kimmelman","year":"2015","unstructured":"Kimmelman AC (2015) Metabolic dependencies in RAS-driven cancers. Clin Cancer Res 21:1828\u20131834. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2425","journal-title":"Clin Cancer Res"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/labinvest.2017.79","volume":"97","author":"MI Koukourakis","year":"2017","unstructured":"Koukourakis MI, Kalamida D, Mitrakas AG et al (2017) Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts. Lab Investig 97:1321\u20131331. https:\/\/doi.org\/10.1038\/labinvest.2017.79","journal-title":"Lab Investig"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.BBRC.2012.05.063","volume":"423","author":"O-H Kwon","year":"2012","unstructured":"Kwon O-H, Kang T-W, Kim J-H et al (2012) Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level. Biochem Biophys Res Commun 423:38\u201344. https:\/\/doi.org\/10.1016\/J.BBRC.2012.05.063","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR82","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2013.12.039","volume":"156","author":"JH Lee","year":"2014","unstructured":"Lee JH, Bhang DH, Beede A et al (2014) Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis. Cell 156:440\u2013455. https:\/\/doi.org\/10.1016\/j.cell.2013.12.039","journal-title":"Cell"},{"key":"16_CR83","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.bbrc.2016.07.028","volume":"477","author":"HN Lee","year":"2016","unstructured":"Lee HN, Ahn SM, Jang HH (2016) Cold-inducible RNA-binding protein promotes epithelial-mesenchymal transition by activating ERK and p38 pathways. Biochem Biophys Res Commun 477:1038\u20131044. https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.028","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR84","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbcan.2015.08.002","volume":"1856","author":"H Lemjabbar-Alaoui","year":"2015","unstructured":"Lemjabbar-Alaoui H, Hassan OU, Yang Y-W, Buchanan P (2015) Lung cancer: biology and treatment options. Biochim Biophys Acta\u00a0\u2013 Rev Cancer 1856:189\u2013210. https:\/\/doi.org\/10.1016\/j.bbcan.2015.08.002","journal-title":"Biochim Biophys Acta\u00a0\u2013 Rev Cancer"},{"key":"16_CR85","doi-asserted-by":"publisher","first-page":"32586","DOI":"10.18632\/oncotarget.15937","volume":"8","author":"W Li","year":"2017","unstructured":"Li W, Gao F, Ma X et al (2017) Deguelin inhibits non-small cell lung cancer via down-regulating hexokinases II-mediated glycolysis. Oncotarget 8:32586\u201332599. https:\/\/doi.org\/10.18632\/oncotarget.15937","journal-title":"Oncotarget"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"E1730","DOI":"10.3390\/molecules21121730","volume":"21","author":"P Lis","year":"2016","unstructured":"Lis P, Dyl\u0105g M, Nied\u017awiecka K et al (2016) The HK2 dependent \u201cWarburg Effect\u201d and mitochondrial oxidative phosphorylation in cancer: targets for effective therapy with 3-bromopyruvate. Molecules 21:E1730. https:\/\/doi.org\/10.3390\/molecules21121730","journal-title":"Molecules"},{"key":"16_CR87","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W et al (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11:1672\u20131682. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0131","journal-title":"Mol Cancer Ther"},{"key":"16_CR88","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3892\/ijo.2017.3979","volume":"50","author":"Y Liu","year":"2017","unstructured":"Liu Y, Murray-Stewart T, Casero RA et al (2017) Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth. Int J Oncol 50:2011\u20132023. https:\/\/doi.org\/10.3892\/ijo.2017.3979","journal-title":"Int J Oncol"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ijc.30752","volume":"141","author":"RJ Lobb","year":"2017","unstructured":"Lobb RJ, van Amerongen R, Wiegmans A et al (2017) Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance. Int J Cancer 141:614\u2013620. https:\/\/doi.org\/10.1002\/ijc.30752","journal-title":"Int J Cancer"},{"key":"16_CR90","first-page":"1","volume":"1","author":"F Lopes-Coelho","year":"2017","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Nunes SC, Serpa J (2017) Metabolic dynamics in breast cancer: cooperation between cancer and stromal breast cancer cells. J Clin Breast Cancer Res 1:1\u20137","journal-title":"J Clin Breast Cancer Res"},{"key":"16_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428318756203","volume":"40","author":"F Lopes-Coelho","year":"2018","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Serpa J (2018) Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression. Tumor Biol 40:1\u201315. https:\/\/doi.org\/10.1177\/1010428318756203","journal-title":"Tumor Biol"},{"key":"16_CR92","doi-asserted-by":"publisher","first-page":"e1462","DOI":"10.1002\/wrna.1462","volume":"9","author":"DA Lujan","year":"2018","unstructured":"Lujan DA, Ochoa JL, Hartley RS (2018) Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip Rev RNA 9:e1462. https:\/\/doi.org\/10.1002\/wrna.1462","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"16_CR93","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis CA, Kimmelman AC (2017) Metabolic interactions in the tumor microenvironment. Trends Cell Biol 27:863\u2013875. https:\/\/doi.org\/10.1016\/j.tcb.2017.06.003","journal-title":"Trends Cell Biol"},{"key":"16_CR94","doi-asserted-by":"publisher","first-page":"20813","DOI":"10.1074\/jbc.M114.575464","volume":"289","author":"H Makinoshima","year":"2014","unstructured":"Makinoshima H, Takita M, Matsumoto S et al (2014) Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma. J Biol Chem 289:20813\u201320823. https:\/\/doi.org\/10.1074\/jbc.M114.575464","journal-title":"J Biol Chem"},{"key":"16_CR95","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/mc.22996","volume":"58","author":"S Mallappa","year":"2019","unstructured":"Mallappa S, Neeli PK, Karnewar S, Kotamraju S (2019) Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: relevance of statins in chemosensitization. Mol Carcinog 58:1118\u20131133. https:\/\/doi.org\/10.1002\/mc.22996","journal-title":"Mol Carcinog"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan S, Hewton K, Monack DM et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213\u2013218. https:\/\/doi.org\/10.1038\/nature02664","journal-title":"Nature"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1021\/pr500327v","volume":"13","author":"A Mart\u00edn-Bernab\u00e9","year":"2014","unstructured":"Mart\u00edn-Bernab\u00e9 A, Cort\u00e9s R, Lehmann SG et al (2014) Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer. J Proteome Res 13:4695\u20134704. https:\/\/doi.org\/10.1021\/pr500327v","journal-title":"J Proteome Res"},{"key":"16_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2014.01.005","volume":"25","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn UE, Lisanti MP, Sotgia F (2014) Catabolic cancer-associated fibroblasts (CAFs) transfer energy and biomass to anabolic cancer cells, Fueling Tumor Growth. Semin Cancer Biol 25:1\u201313. https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.005","journal-title":"Semin Cancer Biol"},{"key":"16_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/metabo9050081","volume":"9","author":"J-P Mazat","year":"2019","unstructured":"Mazat J-P, Ransac S (2019) The fate of glutamine in human metabolism. The interplay with glucose in proliferating cells. Meta 9:81. https:\/\/doi.org\/10.3390\/metabo9050081","journal-title":"Meta"},{"key":"16_CR100","doi-asserted-by":"publisher","unstructured":"Melosky B, Juergens R, Hirsh V et al (2019) Amplifying outcomes: checkpoint inhibitor combinations in first-line non-small cell lung cancer. Oncologist theoncologist.2019-0027. https:\/\/doi.org\/10.1634\/theoncologist.2019-0027","DOI":"10.1634\/theoncologist.2019-0027"},{"key":"16_CR101","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1200\/JCO.2005.02.120","volume":"23","author":"M Michael","year":"2005","unstructured":"Michael M, Doherty MM (2005) Tumoral drug metabolism: overview and its implications for cancer therapy. J Clin Oncol 23:205\u2013229. https:\/\/doi.org\/10.1200\/JCO.2005.02.120","journal-title":"J Clin Oncol"},{"key":"16_CR102","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita T, Narita T, Nomura K et al (2008) ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 68:8547\u20138554. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1235","journal-title":"Cancer Res"},{"key":"16_CR103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4062\/biomolther.2017.211","volume":"26","author":"HY Min","year":"2018","unstructured":"Min HY, Lee HY (2018) Oncogene-driven metabolic alterations in cancer. Biomol Ther 26:45\u201356. https:\/\/doi.org\/10.4062\/biomolther.2017.211","journal-title":"Biomol Ther"},{"key":"16_CR104","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbrc.2013.09.041","volume":"440","author":"JW Min","year":"2013","unstructured":"Min JW, Il KK, Kim H-A et al (2013) INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells. Biochem Biophys Res Commun 440:137\u2013142. https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.041","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR105","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-319-24932-2_5","volume":"890","author":"V Mittal","year":"2016","unstructured":"Mittal V, El Rayes T, Narula N et al (2016a) The microenvironment of lung cancer and therapeutic implications. Adv Exp Med Biol 890:75\u2013110","journal-title":"Adv Exp Med Biol"},{"key":"16_CR106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-319-24932-2_5","volume":"890","author":"V Mittal","year":"2016","unstructured":"Mittal V, El Rayes T, Navneet N (2016b) The microenvironment of lung cancer and therapeutic implications. Adv Exp Med Biol 890:75\u2013110","journal-title":"Adv Exp Med Biol"},{"key":"16_CR107","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.celrep.2016.12.061","volume":"18","author":"M Momcilovic","year":"2017","unstructured":"Momcilovic M, Bailey ST, Lee JT et al (2017) Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer. Cell Rep 18:601\u2013610. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.061","journal-title":"Cell Rep"},{"key":"16_CR108","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1183\/16000617.0031-2015","volume":"24","author":"L Morales-Nebreda","year":"2015","unstructured":"Morales-Nebreda L, Misharin AV, Perlman H, Scott Budinger GR (2015) The heterogeneity of lung macrophages in the susceptibility to disease. Eur Respir Rev 24:505\u2013509. https:\/\/doi.org\/10.1183\/16000617.0031-2015","journal-title":"Eur Respir Rev"},{"key":"16_CR109","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1378\/chest.119.6.1635","volume":"119","author":"S Murin","year":"2003","unstructured":"Murin S, Inciardi J (2003) Cigarette smoking and the risk of pulmonary metastasis from breast cancer. Chest 119:1635\u20131640. https:\/\/doi.org\/10.1378\/chest.119.6.1635","journal-title":"Chest"},{"key":"16_CR110","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.trecan.2016.06.002","volume":"2","author":"A Nagarajan","year":"2016","unstructured":"Nagarajan A, Malvi P, Wajapeyee N (2016) Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2:365\u2013377. https:\/\/doi.org\/10.1016\/j.trecan.2016.06.002","journal-title":"Trends Cancer"},{"key":"16_CR111","doi-asserted-by":"publisher","first-page":"E1882","DOI":"10.3390\/ijms19071882","volume":"19","author":"SC Nunes","year":"2018","unstructured":"Nunes SC, Serpa J (2018) Glutathione in ovarian cancer: a double-edged sword. Int J Mol Sci 19:E1882","journal-title":"Int J Mol Sci"},{"key":"16_CR112","doi-asserted-by":"publisher","first-page":"9513","DOI":"10.1038\/s41598-018-27753-y","volume":"8","author":"SC Nunes","year":"2018","unstructured":"Nunes SC, Ramos C, Lopes-Coelho F et al (2018) Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity. Sci Rep 8:9513. https:\/\/doi.org\/10.1038\/s41598-018-27753-y","journal-title":"Sci Rep"},{"key":"16_CR113","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41584-018-0077-6","volume":"14","author":"S O\u2019Reilly","year":"2018","unstructured":"O\u2019Reilly S, van Laar JM (2018) Targeting the TLR4-MD2 axis in systemic sclerosis. Nat Rev Rheumatol 14:564\u2013566. https:\/\/doi.org\/10.1038\/s41584-018-0077-6","journal-title":"Nat Rev Rheumatol"},{"key":"16_CR114","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0014-5793(97)00340-2","volume":"407","author":"R Onetti","year":"1997","unstructured":"Onetti R, Baulida J, Bassols A (1997) Increased glucose transport in ras-transformed fibroblasts: a possible role for N-glycosylation of GLUT1. FEBS Lett 407:267\u2013270. https:\/\/doi.org\/10.1016\/S0014-5793(97)00340-2","journal-title":"FEBS Lett"},{"key":"16_CR115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10637-012-9862-2","volume":"31","author":"PA Ott","year":"2013","unstructured":"Ott PA, Carvajal RD, Pandit-Taskar N et al (2013) Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Investig New Drugs 31:425\u2013434. https:\/\/doi.org\/10.1007\/s10637-012-9862-2","journal-title":"Investig New Drugs"},{"issue":"6","key":"16_CR116","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"B Otto Warburg","year":"1927","unstructured":"Otto Warburg B, Wind F, Negelein N (1927) The metabolism of tumors in the body. J Gen Physiol 8(6):519\u2013530. https:\/\/doi.org\/10.1085\/jgp.8.6.519","journal-title":"J Gen Physiol"},{"key":"16_CR117","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/bies.201300084","volume":"35","author":"EM Palsson-McDermott","year":"2013","unstructured":"Palsson-McDermott EM, O\u2019Neill LAJ (2013) The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays 35:965\u2013973. https:\/\/doi.org\/10.1002\/bies.201300084","journal-title":"BioEssays"},{"key":"16_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L et al (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187\u2013197. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.012","journal-title":"Cell Metab"},{"key":"16_CR119","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","volume":"24","author":"KC Patra","year":"2013","unstructured":"Patra KC, Wang Q, Bhaskar PT et al (2013) Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 24:213\u2013228. https:\/\/doi.org\/10.1016\/j.ccr.2013.06.014","journal-title":"Cancer Cell"},{"key":"16_CR120","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R et al (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8:3984\u20134001. https:\/\/doi.org\/10.4161\/cc.8.23.10238","journal-title":"Cell Cycle"},{"key":"16_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"16_CR122","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/bjc.2013.118","volume":"108","author":"AI Phipps","year":"2013","unstructured":"Phipps AI, Buchanan DD, Makar KW et al (2013) KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer 108:1757\u20131764. https:\/\/doi.org\/10.1038\/bjc.2013.118","journal-title":"Br J Cancer"},{"key":"16_CR123","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","volume":"82","author":"LA Pikor","year":"2013","unstructured":"Pikor LA, Ramnarine VR, Lam S, Lam WL (2013) Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82:179\u2013189","journal-title":"Lung Cancer"},{"key":"16_CR124","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803\u2013815. https:\/\/doi.org\/10.1038\/nri2171","journal-title":"Nat Rev Immunol"},{"key":"16_CR125","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nrc3106","volume":"19","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D (2011) RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nrc3106","journal-title":"Nat Rev Cancer"},{"key":"16_CR126","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/cam4.819","volume":"5","author":"A Qin","year":"2016","unstructured":"Qin A, Coffey DG, Warren EH, Ramnath N (2016) Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer. Cancer Med 5:2567\u20132578. https:\/\/doi.org\/10.1002\/cam4.819","journal-title":"Cancer Med"},{"key":"16_CR127","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"16_CR128","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/ijc.28726","volume":"135","author":"KCS Queiroz","year":"2014","unstructured":"Queiroz KCS, Shi K, Duitman J et\u00a0al (2014) Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance. Int J Cancer 135:2294\u20132304. https:\/\/doi.org\/10.1002\/ijc.28726","journal-title":"Int J Cancer"},{"key":"16_CR129","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/1873-3468.12771","volume":"591","author":"K Rabold","year":"2017","unstructured":"Rabold K, Netea MG, Adema GJ, Netea-Maier RT (2017) Cellular metabolism of tumor-associated macrophages\u00a0\u2013 functional impact and consequences. FEBS Lett 591:3022\u20133041. https:\/\/doi.org\/10.1002\/1873-3468.12771","journal-title":"FEBS Lett"},{"key":"16_CR130","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4049\/jimmunol.171.3.1232","volume":"171","author":"PC Rodriguez","year":"2003","unstructured":"Rodriguez PC, Zea AH, DeSalvo J et\u00a0al (2003) L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 171:1232\u20131239. https:\/\/doi.org\/10.4049\/jimmunol.171.3.1232","journal-title":"J Immunol"},{"key":"16_CR131","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","volume":"109","author":"PC Rodriguez","year":"2007","unstructured":"Rodriguez PC, Quiceno DG, Ochoa AC (2007) L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109:1568\u20131573. https:\/\/doi.org\/10.1182\/blood-2006-06-031856","journal-title":"Blood"},{"key":"16_CR132","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-15-0798","volume":"75","author":"K Rycaj","year":"2015","unstructured":"Rycaj K, Tang DG (2015) Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res 75:4003\u20134011. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0798","journal-title":"Cancer Res"},{"key":"16_CR133","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djx160","volume":"110","author":"A Salem","year":"2018","unstructured":"Salem A, Asselin M-C, Reymen B et al (2018) Targeting hypoxia to improve non\u2013small cell lung cancer outcome. JNCI J Natl Cancer Inst 110:14\u201330. https:\/\/doi.org\/10.1093\/jnci\/djx160","journal-title":"JNCI J Natl Cancer Inst"},{"key":"16_CR134","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors S, Bruning U, Missiaen R et al (2015) Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520:192\u2013197. https:\/\/doi.org\/10.1038\/nature14362","journal-title":"Nature"},{"key":"16_CR135","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI72873","volume":"125","author":"K Sellers","year":"2015","unstructured":"Sellers K, Fox MP, Ii MB et al (2015) Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest 125:687\u2013698. https:\/\/doi.org\/10.1172\/JCI72873","journal-title":"J Clin Invest"},{"key":"16_CR136","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cell.2011.10.003","volume":"147","author":"DB Sen","year":"2011","unstructured":"Sen DB, Nolan DJ, Guo P et al (2011) Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 147:539\u2013553. https:\/\/doi.org\/10.1016\/j.cell.2011.10.003","journal-title":"Cell"},{"key":"16_CR137","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4161\/cc.10.2.14476","volume":"10","author":"J Serpa","year":"2011","unstructured":"Serpa J, Dias S (2011) Metabolic cues from the microenvironment act as a major selective factor for cancer progression and metastases formation. Cell Cycle 10:180\u2013181. https:\/\/doi.org\/10.4161\/cc.10.2.14476","journal-title":"Cell Cycle"},{"key":"16_CR138","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, Wang R, Huang G et al (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208:1367\u20131376. https:\/\/doi.org\/10.1084\/jem.20110278","journal-title":"J Exp Med"},{"key":"16_CR139","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14:611\u2013629. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44","journal-title":"Nat Rev Clin Oncol"},{"key":"16_CR140","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H, Lin L, Takahashi T et al (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. JNCI J Natl Cancer Inst 97:339\u2013346. https:\/\/doi.org\/10.1093\/jnci\/dji055","journal-title":"JNCI J Natl Cancer Inst"},{"key":"16_CR141","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H et al (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:101\u2013105. https:\/\/doi.org\/10.1038\/nature12040","journal-title":"Nature"},{"key":"16_CR142","doi-asserted-by":"publisher","first-page":"17531","DOI":"10.1073\/pnas.1207238109","volume":"109","author":"H Song","year":"2012","unstructured":"Song H, Yao E, Lin C et al (2012) Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis. Proc Natl Acad Sci 109:17531\u201317536. https:\/\/doi.org\/10.1073\/pnas.1207238109","journal-title":"Proc Natl Acad Sci"},{"key":"16_CR143","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2014.07.012","volume":"15","author":"H Song","year":"2014","unstructured":"Song H, Yao E, Lin C et al (2014) Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 15:123\u2013138. https:\/\/doi.org\/10.1016\/j.stem.2014.07.012","journal-title":"Cell Stem Cell"},{"key":"16_CR144","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2016.4600","volume":"12","author":"K Song","year":"2016","unstructured":"Song K, Li M, Xu X et al (2016) Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia. Oncol Lett 12:334\u2013342. https:\/\/doi.org\/10.3892\/ol.2016.4600","journal-title":"Oncol Lett"},{"key":"16_CR145","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees JL, Olson SD, Whitney MJ, Prockop DJ (2006) Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci 103:1283\u20131288. https:\/\/doi.org\/10.1073\/pnas.0510511103","journal-title":"Proc Natl Acad Sci"},{"key":"16_CR146","doi-asserted-by":"publisher","first-page":"e29528","DOI":"10.4161\/tisb.29528","volume":"2","author":"SK Sriraman","year":"2014","unstructured":"Sriraman SK, Aryasomayajula B, Torchilin VP (2014) Barriers to drug delivery in solid tumors. Tissue Barriers 2:e29528. https:\/\/doi.org\/10.4161\/tisb.29528","journal-title":"Tissue Barriers"},{"key":"16_CR147","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1158\/1541-7786.mcr-07-0309","volume":"6","author":"GT Stathopoulos","year":"2008","unstructured":"Stathopoulos GT, Sherrill TP, Han W et al (2008) Host nuclear factor- B activation potentiates lung cancer metastasis. Mol Cancer Res 6:364\u2013371. https:\/\/doi.org\/10.1158\/1541-7786.mcr-07-0309","journal-title":"Mol Cancer Res"},{"key":"16_CR148","doi-asserted-by":"publisher","first-page":"e1571389","DOI":"10.1080\/2162402X.2019.1571389","volume":"8","author":"G Stoll","year":"2019","unstructured":"Stoll G, Kremer M, Bloy N et al (2019) Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology 8:e1571389. https:\/\/doi.org\/10.1080\/2162402X.2019.1571389","journal-title":"Oncoimmunology"},{"key":"16_CR149","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/bjc.2013.187","volume":"108","author":"Y Storozhuk","year":"2013","unstructured":"Storozhuk Y, Hopmans SN, Sanli T et al (2013) Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J Cancer 108:2021\u20132032. https:\/\/doi.org\/10.1038\/bjc.2013.187","journal-title":"Br J Cancer"},{"key":"16_CR150","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S1470-2045(08)70174-8","volume":"9","author":"J Subramanian","year":"2008","unstructured":"Subramanian J, Govindan R (2008) Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol 9:676\u2013682. https:\/\/doi.org\/10.1016\/S1470-2045(08)70174-8","journal-title":"Lancet Oncol"},{"key":"16_CR151","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/MOH.0000000000000335","volume":"24","author":"LA Teuwen","year":"2017","unstructured":"Teuwen LA, Draoui N, Dubois C, Carmeliet P (2017) Endothelial cell metabolism: an update anno 2017. Curr Opin Hematol 24:240\u2013247. https:\/\/doi.org\/10.1097\/MOH.0000000000000335","journal-title":"Curr Opin Hematol"},{"key":"16_CR152","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M (2010) Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab 298:E141\u2013E145. https:\/\/doi.org\/10.1152\/ajpendo.00712.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"16_CR153","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2217\/fon.11.100","volume":"7","author":"S Torok","year":"2011","unstructured":"Torok S, Hegedus B, Laszlo V et al (2011) Lung cancer in never smokers. Future Oncol 7:1195\u20131211. https:\/\/doi.org\/10.2217\/fon.11.100","journal-title":"Future Oncol"},{"key":"16_CR154","doi-asserted-by":"publisher","first-page":"e17558","DOI":"10.1200\/jco.2012.30.15_suppl.e17558","volume":"30","author":"S Tran","year":"2012","unstructured":"Tran S, Ready N, Krug LM, Pietanza MC, Jungbluth AA, Pan LS, Venhaus RR, Hoffman EW, Peters A-M, Dukelow K, Bomalaski JS, Wu B-W, LJO (2012) Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer. J Clin Oncol 30:e17558\u2013e17558","journal-title":"J Clin Oncol"},{"key":"16_CR155","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"key":"16_CR156","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science"},{"key":"16_CR157","doi-asserted-by":"publisher","unstructured":"Vander Linden C, Corbet C (2019) Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncology. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.016","DOI":"10.1016\/j.semcdb.2019.05.016"},{"key":"16_CR158","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/annonc\/mdz175","volume":"30","author":"J Vansteenkiste","year":"2019","unstructured":"Vansteenkiste J, Wauters E, Reymen B et al (2019) Current status of immune checkpoint inhibition in early stage NSCLC. Ann Oncol 30:1244\u20131253. https:\/\/doi.org\/10.1093\/annonc\/mdz175","journal-title":"Ann Oncol"},{"key":"16_CR159","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-018-0345-z","volume":"9","author":"R Vegliante","year":"2018","unstructured":"Vegliante R, Di Leo L, Ciccarone F, Ciriolo MR (2018) Hints on ATGL implications in cancer: beyond bioenergetic clues. Cell Death Dis 9:316. https:\/\/doi.org\/10.1038\/s41419-018-0345-z","journal-title":"Cell Death Dis"},{"key":"16_CR160","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/bjc.1997.201","volume":"75","author":"V Vukovic","year":"1997","unstructured":"Vukovic V, Tannock IF (1997) Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Br J Cancer 75:1167\u20131172","journal-title":"Br J Cancer"},{"key":"16_CR161","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/J.IMMUNI.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang R, Dillon CP, Shi LZ et al (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35:871\u2013882. https:\/\/doi.org\/10.1016\/J.IMMUNI.2011.09.021","journal-title":"Immunity"},{"issue":"9","key":"16_CR162","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12935-016-0280-y","volume":"16","author":"H Wang","year":"2016","unstructured":"Wang H, Wang L, Zhang Y et al (2016) Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int 16(9):9. https:\/\/doi.org\/10.1186\/s12935-016-0280-y","journal-title":"Cancer Cell Int"},{"key":"16_CR163","doi-asserted-by":"publisher","first-page":"76116","DOI":"10.18632\/oncotarget.18814","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Cao L, Wang H et al (2017a) Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway. Oncotarget 8:76116\u201376128. https:\/\/doi.org\/10.18632\/oncotarget.18814","journal-title":"Oncotarget"},{"key":"16_CR164","doi-asserted-by":"publisher","first-page":"45983","DOI":"10.1038\/srep45983","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang F, Wu X-R (2017b) Inhibition of pyruvate kinase M2 markedly reduces chemoresistance of advanced bladder cancer to cisplatin. Sci Rep 7:45983. https:\/\/doi.org\/10.1038\/srep45983","journal-title":"Sci Rep"},{"key":"16_CR165","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hao F, Nan Y et al (2018) PKM2 inhibitor Shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis. Int J Biol Sci 14:1883\u20131891. https:\/\/doi.org\/10.7150\/ijbs.27854","journal-title":"Int J Biol Sci"},{"key":"16_CR166","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/cas.13998","volume":"110","author":"L Wang","year":"2019","unstructured":"Wang L, Li X, Ren Y et al (2019a) Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA 3 in lung cancer cells. Cancer Sci 110:1609\u20131620. https:\/\/doi.org\/10.1111\/cas.13998","journal-title":"Cancer Sci"},{"key":"16_CR167","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.LFS.2019.05.030","volume":"229","author":"R Wang","year":"2019","unstructured":"Wang R, Lou X, Feng G et al (2019b) IL-17A-stimulated endothelial fatty acid \u03b2-oxidation promotes tumor angiogenesis. Life Sci 229:46\u201356. https:\/\/doi.org\/10.1016\/J.LFS.2019.05.030","journal-title":"Life Sci"},{"key":"16_CR168","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314. https:\/\/doi.org\/10.1126\/science.123.3191.309","journal-title":"Science"},{"key":"16_CR169","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/BF01712130","volume":"2","author":"O Warburg","year":"1923","unstructured":"Warburg O, Minami S (1923) Versuche an \u00dcberlebendem Carcinomgewebe. Klin Wochenschr 2:776\u2013777","journal-title":"Klin Wochenschr"},{"key":"16_CR170","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.tox.2017.07.016","volume":"391","author":"AP West","year":"2017","unstructured":"West AP (2017) Mitochondrial dysfunction as a trigger of innate immune responses and inflammation. Toxicology 391:54\u201363. https:\/\/doi.org\/10.1016\/j.tox.2017.07.016","journal-title":"Toxicology"},{"key":"16_CR171","doi-asserted-by":"publisher","unstructured":"Woo CG, Seo S, Kim SW et al (2016) Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK -rearranged non\u2013small cell lung cancer. Ann Oncol:mdw693. https:\/\/doi.org\/10.1093\/annonc\/mdw693","DOI":"10.1093\/annonc\/mdw693"},{"key":"16_CR172","first-page":"3938","volume":"7","author":"Y-Y Xu","year":"2014","unstructured":"Xu Y-Y, Wu T-T, Zhou S-H et al (2014) Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study. Int J Clin Exp Pathol 7:3938\u20133947","journal-title":"Int J Clin Exp Pathol"},{"key":"16_CR173","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/J.BBRC.2016.01.131","volume":"470","author":"H Yan","year":"2016","unstructured":"Yan H, Guo B-Y, Zhang S (2016) Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling. Biochem Biophys Res Commun 470:947\u2013954. https:\/\/doi.org\/10.1016\/J.BBRC.2016.01.131","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR174","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10637-012-9807-9","volume":"31","author":"T Yau","year":"2013","unstructured":"Yau T, Cheng PN, Chan P et al (2013) A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma. Investig New Drugs 31:99\u2013107. https:\/\/doi.org\/10.1007\/s10637-012-9807-9","journal-title":"Investig New Drugs"},{"key":"16_CR175","doi-asserted-by":"publisher","unstructured":"Yeldag G, Rice A, Del R\u00edo Hern\u00e1ndez A (2018) Chemoresistance and the self-maintaining tumor microenvironment. Cancers (Basel) 10. https:\/\/doi.org\/10.3390\/cancers10120471","DOI":"10.3390\/cancers10120471"},{"key":"16_CR176","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA et al (2012) Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:656\u2013670. https:\/\/doi.org\/10.1016\/j.cell.2012.01.058","journal-title":"Cell"},{"key":"16_CR177","doi-asserted-by":"publisher","first-page":"e0129593","DOI":"10.1371\/journal.pone.0129593","volume":"10","author":"L Ying","year":"2015","unstructured":"Ying L, Zhu Z, Xu Z et al (2015) Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung cancer A549 cells by up-regulating the PI3K\/Akt and GRP78 signaling on a microfluidic platform. PLoS One 10:e0129593. https:\/\/doi.org\/10.1371\/journal.pone.0129593","journal-title":"PLoS One"},{"key":"16_CR178","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3349\/ymj.2016.57.6.1312","volume":"57","author":"S Yuan","year":"2016","unstructured":"Yuan S, Qiao T, Zhuang X et al (2016) Knockdown of the M2 isoform of pyruvate kinase (PKM2) with shRNA enhances the effect of docetaxel in human NSCLC cell lines in vitro. Yonsei Med J 57:1312\u20131323. https:\/\/doi.org\/10.3349\/ymj.2016.57.6.1312","journal-title":"Yonsei Med J"},{"key":"16_CR179","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.anndiagpath.2019.05.007","volume":"41","author":"M Zengin","year":"2019","unstructured":"Zengin M (2019) Prognostic role of tumour-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: a broad methodological study in a fairly homogeneous population. Ann Diagn Pathol 41:69\u201378. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.05.007","journal-title":"Ann Diagn Pathol"},{"key":"16_CR180","doi-asserted-by":"publisher","first-page":"497","DOI":"10.18632\/oncotarget.186","volume":"1","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology abstract: abbreviations used. Oncotarget 1:497\u2013514","journal-title":"Oncotarget"},{"key":"16_CR181","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cell.2011.11.050","volume":"148","author":"WC Zhang","year":"2012","unstructured":"Zhang WC, Ng SC, Yang H et al (2012) Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148:259\u2013272. https:\/\/doi.org\/10.1016\/j.cell.2011.11.050","journal-title":"Cell"},{"key":"16_CR182","doi-asserted-by":"publisher","first-page":"78985","DOI":"10.18632\/oncotarget.12587","volume":"7","author":"Y-L Zhang","year":"2016","unstructured":"Zhang Y-L, Yuan J-Q, Wang K-F et al (2016) The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 7:78985\u201378993. https:\/\/doi.org\/10.18632\/oncotarget.12587","journal-title":"Oncotarget"},{"key":"16_CR183","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2016.11.005","volume":"42","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wang DC, Shi L et al (2017a) Genome analyses identify the genetic modification of lung cancer subtypes. Semin Cancer Biol 42:20\u201330. https:\/\/doi.org\/10.1016\/j.semcancer.2016.11.005","journal-title":"Semin Cancer Biol"},{"key":"16_CR184","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-017-0704-x","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, Song F, Zhao X et al (2017b) EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer. Mol Cancer 16:127. https:\/\/doi.org\/10.1186\/s12943-017-0704-x","journal-title":"Mol Cancer"},{"key":"16_CR185","doi-asserted-by":"publisher","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yao Y, Zhang S et al (2019) Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med 11:eaau1167. https:\/\/doi.org\/10.1126\/scitranslmed.aau1167","journal-title":"Sci Transl Med"},{"key":"16_CR186","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/J.PHARMTHERA.2016.02.008","volume":"160","author":"J Zhao","year":"2016","unstructured":"Zhao J (2016) Cancer stem cells and chemoresistance: the smartest survives the raid. Pharmacol Ther 160:145\u2013158. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2016.02.008","journal-title":"Pharmacol Ther"},{"key":"16_CR187","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12951-017-0316-z","volume":"15","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wen H, Gu L et al (2017) Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. J Nanobiotechnol 15:87. https:\/\/doi.org\/10.1186\/s12951-017-0316-z","journal-title":"J Nanobiotechnol"},{"key":"16_CR188","doi-asserted-by":"publisher","first-page":"30788","DOI":"10.1038\/srep30788","volume":"6","author":"H Zhu","year":"2016","unstructured":"Zhu H, Wu J, Zhang W et al (2016) PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer. Sci Rep 6:30788. https:\/\/doi.org\/10.1038\/srep30788","journal-title":"Sci Rep"},{"key":"16_CR189","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/HP.S99044","volume":"4","author":"AD Zimmer","year":"2016","unstructured":"Zimmer AD, Walbrecq G, Kozar I et al (2016) Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells. Hypoxia 4:135\u2013145. https:\/\/doi.org\/10.2147\/HP.S99044","journal-title":"Hypoxia"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-34025-4_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T10:16:44Z","timestamp":1708337804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-34025-4_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030340247","9783030340254"],"references-count":189,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-34025-4_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"5 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}